As Single Use Support is presenting one of its technologies at the Interphex in New York, Interphex created a quick questionnaire to learn more about Single Use Support GmbH. CEO Johannes Kirchmair gave them all the answers.
Over the last few years, “Single Use Support” has been developing BULK.STREAM® – a virtually 100% secure logistics process for fluids in the biopharmaceutical industry. The new innovations will be presented at the Interphex, the leading fair for pharmaceutical and biotech professionals in New York from 2 until 4 April.
The young startup from the Tyrolean Alps will present one of its technologies at the Interphex in New York. In the past years, “Single Use Support” was busy developing an entire logistics process for the shipping of biopharmaceutical liquid goods.
Go no further – Single Use Technology has and is the solution for you and your patients. The financial and operational benefits are manifold and will blast traditional processes into the past. We are backing this statement with 5 indisputable reasons to demonstrate why biopharmaceutical companies should solely be using Single Use Technology.
According to the biopharmaceutical industry, the loss of drug substances is higher than 1% for CAR-T cell therapies. Rumor has it that the actual loss rate is even higher. In other words, this means that only 99 out of 100 patients will receive fully functional CAR-T therapy.
Single-use technology is quickly gaining in popularity around the world because of the financial and operational benefits over traditional process methods using stainless steel. So, why should a biopharmaceutical manufacturer adopt single-use technology (SUT) in their bioprocess? Here are 5 reasons.
One of the main issues of the CAR-T cell therapy is no less than banal – it is logistics. The pharmaceutical industry, which is focused on shipping large amounts of drug substances, is lacking reasonable and realistic solutions for the agile and secure worldwide shipping of small batches that are required for the CAR-T cell therapy, where frozen bags with a volume of 50 ml to 0.5 L are sufficient. We found a solution.
“Young entrepreneurs’ walk of fame” – that was the motto for the tenth Young Entrepreneurs’ Award (Jungunternehmerpreis) awarded by “Junge Wirtschaft Tirol” at the WIFI Campus in Innsbruck. The winners in the category “New Ideas – New Products – New Markets” are from Kufstein: Johannes Kirchmair and Thomas Wurms impressed the jury with their young start-up “Single Use Support GmbH”.
In November, Single Use Support GmbH Founder Johannes Kirchmaier presented the company’s newest development, the MITS.2D at the U.S. Food and Drug Administration (FDA) headquarters in Washington to more than 60 industry experts.
As has been the case since 1993, the Tyrolean Chamber of Commerce recently awarded outstandingly innovative Tyrolean enterprises with the 2018 Tyrolean Innovation Price. On October 8th, Single Use Support was awarded first place in the “Technical Innovation” category.